A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy - PubMed (original) (raw)
Comparative Study
A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy
C M Nutting et al. Radiother Oncol. 2001 Nov.
Abstract
Background and purpose: To investigate the potential of intensity-modulated radiotherapy (IMRT) to reduce lung irradiation in the treatment of oesophageal carcinoma with radical radiotherapy.
Materials and methods: A treatment planning study was performed to compare two-phase conformal radiotherapy (CFRT) with IMRT in five patients. The CFRT plans consisted of anterior, posterior and bilateral posterior oblique fields, while the IMRT plans consisted of either nine equispaced fields (9F), or four fields (4F) with orientations equal to the CFRT plans. IMRT plans with seven, five or three equispaced fields were also investigated in one patient. Treatment plans were compared using dose-volume histograms and normal tissue complication probabilities.
Results: The 9F IMRT plan was unable to improve on the homogeneity of dose to the planning target volume (PTV), compared with the CFRT plan (dose range, 16.9+/-4.5 (1 SD) vs. 12.4+/-3.9%; P=0.06). Similarly, the 9F IMRT plan was unable to reduce the mean lung dose (11.7+/-3.2 vs. 11.0+/-2.9 Gy; P=0.2). Similar results were obtained for seven, five and three equispaced fields in the single patient studied. The 4F IMRT plan provided comparable PTV dose homogeneity with the CFRT plan (11.8+/-3.3 vs. 12.4+/-3.9%; P=0.6), with reduced mean lung dose (9.5+/-2.3 vs 11.0+/-2.9 Gy; P=0.001).
Conclusions: IMRT using nine equispaced fields provided no improvement over CFRT. This was because the larger number of fields in the IMRT plan distributed a low dose over the entire lung. In contrast, IMRT using four fields equal to the CFRT fields offered an improvement in lung sparing. Thus, IMRT with a few carefully chosen field directions may lead to a modest reduction in pneumonitis, or allow tumour dose escalation within the currently accepted lung toxicity.
Similar articles
- Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes.
Lomax AJ, Cella L, Weber D, Kurtz JM, Miralbell R. Lomax AJ, et al. Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):785-92. doi: 10.1016/s0360-3016(02)04210-4. Int J Radiat Oncol Biol Phys. 2003. PMID: 12573766 - Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland.
Nutting CM, Convery DJ, Cosgrove VP, Rowbottom C, Vini L, Harmer C, Dearnaley DP, Webb S. Nutting CM, et al. Radiother Oncol. 2001 Aug;60(2):173-80. doi: 10.1016/s0167-8140(01)00382-6. Radiother Oncol. 2001. PMID: 11439212 - Optimisation of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal, and intensity-modulated techniques.
Nutting CM, Rowbottom CG, Cosgrove VP, Henk JM, Dearnaley DP, Robinson MH, Conway J, Webb S. Nutting CM, et al. Radiother Oncol. 2001 Aug;60(2):163-72. doi: 10.1016/s0167-8140(01)00339-5. Radiother Oncol. 2001. PMID: 11439211 Clinical Trial. - [Dosimetric comparison between intensity-modulated radiotherapy and conformal radiotherapy for upper thoracic esophageal carcinoma].
Zhang WZ, Chen ZJ, Li DR, Lin ZX, Li DS, Chen CZ. Zhang WZ, et al. Ai Zheng. 2009 Nov;28(11):1127-31. doi: 10.5732/cjc.008.10839. Ai Zheng. 2009. PMID: 19895730 Chinese.
Cited by
- Radiation Pneumonitis after Intensity-Modulated Radiotherapy for Esophageal Cancer: Institutional Data and a Systematic Review.
Tonison JJ, Fischer SG, Viehrig M, Welz S, Boeke S, Zwirner K, Klumpp B, Braun LH, Zips D, Gani C. Tonison JJ, et al. Sci Rep. 2019 Feb 19;9(1):2255. doi: 10.1038/s41598-018-38414-5. Sci Rep. 2019. PMID: 30783157 Free PMC article. - Preoperative neoadjuvant chemoradiotherapy provides borderline resectable thoracic esophageal cancer with equivalent treatment results as clinically T3 thoracic esophageal cancer.
Wakita A, Motoyama S, Sato Y, Nagaki Y, Fujita H, Kemuriyama K, Hayashi K, Imai K, Nanjo H, Minamiya Y. Wakita A, et al. Ann Gastroenterol Surg. 2023 Jun 11;7(6):904-912. doi: 10.1002/ags3.12706. eCollection 2023 Nov. Ann Gastroenterol Surg. 2023. PMID: 37927919 Free PMC article. - Principles of modern radiation techniques for esophageal and gastroesophageal junction cancers.
Yang GY, McClosky SA, Khushalani NI. Yang GY, et al. Gastrointest Cancer Res. 2009 Mar;3(2 Suppl):S6-S10. Gastrointest Cancer Res. 2009. PMID: 19461922 Free PMC article. - Association between XRCC1 and ERCC1 single-nucleotide polymorphisms and the efficacy of concurrent radiochemotherapy in patients with esophageal squamous cell carcinoma.
Huang X, Liu C, Cui Y, Zhang H, Liu Y, Zhou X, Luo J. Huang X, et al. Oncol Lett. 2017 Feb;13(2):704-714. doi: 10.3892/ol.2016.5496. Epub 2016 Dec 14. Oncol Lett. 2017. PMID: 28356949 Free PMC article. - Knowledge domains and emerging trends in radiotherapy in oesophageal cancer from 2004 to 2023: a bibliometric analysis and visualization study.
Feng Y, Lv M, Zeng S, Zeng H, Yu J. Feng Y, et al. J Radiat Res. 2024 Jul 22;65(4):433-449. doi: 10.1093/jrr/rrae040. J Radiat Res. 2024. PMID: 38842165 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical